Arkolith/Insider Trading/OTLK/Form 4

GMS Ventures & Investments

Director, 10% OwnerOutlook Therapeutics, Inc. (OTLK) · full profile →Form 4 · filed Jan 22, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
0 non-derivative · 5 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 17, 2025Option exercise(M)3.5M——0
Jan 17, 2025Grant(A)3.5M——3.5M
Jan 17, 2025Grant(A)3.5M——3.5M
Jan 17, 2025Disposed to issuer(D)3.5M——0
Jan 17, 2025Grant(A)3.5M——3.5M

Transaction Codes

M
Option exercise / conversion
A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000947871-25-000062) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML